Optimization of the mobile phase composition for preparative chiral separation of flurbiprofen enantiomers

Separation and Purification Technology

Volumn 68, Issue 1, 2009, Pages 9-23

  Ribeiro, António E ^a   Graça, Nuno S ^a   Pais, Luís S ^a   Rodrigues, Alírio E ^b  

^a INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Enantiomer separation; Flurbiprofen; Mobile phase composition; Preparative chromatography; Simulated moving bed

Indexed keywords

ENANTIOMER SEPARATION; FLURBIPROFEN; MOBILE PHASE COMPOSITION; PREPARATIVE CHROMATOGRAPHY; SIMULATED MOVING BED;

ADSORPTION; ADSORPTION ISOTHERMS; ATMOSPHERIC TEMPERATURE; CHROMATOGRAPHIC ANALYSIS; COLUMN CHROMATOGRAPHY; ENANTIOMERS; LIQUID CHROMATOGRAPHY; OPTIMIZATION; PHASE COMPOSITION; SEPARATION;

CHIRALITY;

EID: 67349208398     PISSN: 13835866     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seppur.2009.03.049     Document Type: Article

References (38)

1. Ribeiro A., Graça N., Pais L., and Rodrigues A. Preparative separation of ketoprofen enantiomers: choice of mobile phase composition and measurement of competitive adsorption isotherms. Sep. Purif. Technol. 61 (2008) 375-383
2. Groot D., Vries E., Groen H., and Jong S. Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit. Rev. Oncol. Hematol. 61 (2007) 52-69
3. Zemskova M., Wetcher W., Bashkirova S., Chen C., Reiter R., and Lilly M. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase. Biochem. Pharmacol. 72 (2006) 1257-1267
4. Andrews P., Zhao X., Allen J., Li F., and Chang M. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro. Cancer Chemother. Pharmacol. March (2007)
5. NTR-dependent decreased survival of prostate tumor cells. Cancer Res. 67 (2007) 3254-3262
6. Min/+ (Min) mouse with R-flurbiprofen. Life Sci. 66 (2000) 745-753
7. Grösch S., Schilling K., Janssen A., Maier T., Niederberger E., and Geisslinger G. Induction of apoptosis by R-Flurbiprofen in human colon carcinoma cells: involvement of p53. Biochem. Pharmacol. 69 (2005) 831-839
8. Szekely C., Thorne J., Zandi P., Ek M., Messias E., Breitner J., and Goodman S. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23 (2004) 159-169
9. Mohs R., Kawas C., and Carrillo M. Optimal design of clinical trial for drugs designed to slow the course of Alzheimer's disease. Alzheimer's Dement. 2 (2006) 131-139
10. Wilcock G. Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-flurbiprofen. Alzheimer's Dement. 2 (2006) 150-152
11. McGeer P., and McGeer E. NSAIDs and Alzheimer's disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28 (2007) 639-647
12. Bojarski J., Aboul-Enein H., and Ghanem A. What's new in chromatographic enantioseparations. Curr. Anal. Chem. 1 (2005) 59-77
13. Patel B., Valentova J., and Hutt A. Chromatographic separation and enantiomeric resolution of flurbiprofen and its major metabolites. Chromatographia 55 (2002) 135-142
14. Patel B., Valentova J., and Hutt A. Stereospecific analysis of flurbiprofen and its major metabolites in plasma and urine by chiral-phase liquid chromatography. Chromatographia 57 (2003) 7-18
15. Booth T., and Wainer I. Mechanistic investigation into the enantioselective separation of mexiletine and related compounds, chromatographed on an amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phase. J. Chromatogr. A 741 (1996) 205-211
16. Duan G., and Ching C. Preparative scale enantioseparation of flurbiprofen by lipase-catalysed reaction. Biochem. Eng. J. 2 (1998) 237-245
17. Zhang H., Wang X., and Ching C. R-stereopreference analysis of Lipase Novozym 435 in kinetic resolution of flurbiprofen. Chirality 19 (2007) 245-249
18. Qian L., Chen S., and Shi B. Preparation of enantiopure (R)-flurbiprofen catalysed by a newly isolated Bacillus cereus C71. Biocatal. Biotransf. 25 1 (2007) 29-34
19. Lee E., Won H., Ro H., Ryu Y., and Chung B. Preparation of enantiomerically pure (S)-flurbiprofen by an esterase from Pseudomonas sp. KCTC 10122BP. J. Mol. Catal. B: Enzym. 26 (2003) 149-156
20. Shin G., Lee K., Kim T., Shin H., and Lee Y. Lipase-catalyzed production of optically active (S)-flurbiprofen in aqueous phase reaction system containing chiral succinyl β-cyclodextrin. J. Mol. Catal. B: Enzym. 33 (2005) 93-98
21. Shin G., Lee K., and Lee Y. Fed-batch production of (S)-flurbiprofen in lipase-catalysed dispersed aqueous phase reaction system induced by succinyl β-cyclodextrin and its extractive purification. J. Mol. Catal. B: Enzym. 37 (2005) 109-111
22. Mazzotti M., Storti G., and Morbidelli M. Optimal operation of simulated moving bed units for nonlinear chromatographic separations. J. Chromatogr. A 769 (1997) 3-24
23. Pais L.S., Loureiro J.M., and Rodrigues A.E. Modeling, simulation and operation of a simulated moving bed for continuous chromatographic separation of 1,1′-bi-2-naphthol enantiomers. J. Chromatogr. A 769 (1997) 25-35
24. Pais L.S., Loureiro J.M., and Rodrigues A.E. Separation of enantiomers of a chiral epoxide by simulated moving bed chromatography. J. Chromatogr. A 827 (1998) 215-233
25. Azevedo D.C.S., and Rodrigues A.E. Design of a simulated moving bed in the presence of mass-transfer resistances. AIChE J. 45 (1999) 956-966
26. Migliorini C., Gentilini A., Mazzotti M., and Morbidelli M. Design of simulated moving bed units under nonideal conditions. Ind. Eng. Chem. Res. 38 (1999) 2400-2410
27. Biressi G., Ludemann-Hombourger O., Mazzotti M., Nicoud R.M., and Morbidelli M. Design and optimisation of a simulated moving bed unit: role of deviations from equilibrium theory. J. Chromatogr. A 876 (2000) 3-15
28. Rodrigues A.E., and Pais L.S. Design of SMB chiral separations using the concept of separation volume. Sep. Sci. Technol. 39 (2004) 245-270
29. Pais L.S., Mata V.G., and Rodrigues A.E. Simulated moving bed and related techniques. In: Cox G. (Ed). Preparative Enantioselective Chromatography (2005), Blackwell Publishing, Oxford, UK 176 (Chapter 7)
30. Gracin S., and Rasmunson A. Solubility of phenylacetic acid, p-hydroxyphenylacetic acid, p-aminophenylacetic acid, p-hydroxybenzoic acid, and ibuprofen in pure solvents. J. Chem. Eng. Data 47 (2002) 1379-1383
31. Lynam K., and Stringham R. Chiral separations on polysaccharide stationary phases using polar organic mobile phases. Chirality 18 (2006) 1-9
32. J. Sørensen, W. Arlt, Liquid-Liquid Equilibrium Data Collection: Binary Systems, in DECHEMA, Chemistry Data Series, vol. V, Part 1, 1979.
33. Trejo A., Yañez P., and Rincón R. Liquid-liquid coexistence curves for binary systems: methanol + cyclohexane + several isomers of hexane. J. Chem. Eng. Data 51 (2006) 1070-1075
34. Blackwell J. Effect of acidic mobile phase additives on chiral selectivity for phenylalanine analogs using subcritical fluid chromatography. Chirality 11 (1999) 91-97
35. Ye Y., and Stringham R. Effect of a mobile phase acidic additives on enantioselectivity for phenylalanine analogs. J. Chromatogr. A 927 (2001) 47-52
36. Ye Y., Lord B., and Stringham R. Memory effect of mobile phase additives in chiral separations on a Chiralpak AD column. J. Chromatogr. A 945 (2002) 139-146
37. Ye Y., Lord B., Yin L., and Stringham R. Enantioseparation of amino acids on a polysaccharide-based chiral stationary phase. J. Chromatogr. A 945 (2002) 147-159
38. Matthijs N., Maftouh M., and Heyden Y. Screening approach for chiral separation of pharmaceuticals IV. Polar organic solvent chromatography. J. Chromatogr. A 1111 (2006) 48-61